€6B AUM, 377 portfolio companies 20+ yearswebsite
131 professionals, 15 internal promotions 2026website
Acto V closed €1.1B, above hard capexternal
Andera Expansion IV €430M record fundraisetwitter
Tubulis acquired by Gilead, up to $5Bexternal
Agomab Nasdaq listing, $200M raisedexternal
Real Deals Best Multi-Strategy House 2026external
Joins European Life Sciences Coalition ELSCtwitter
Rivermark Medical $20M Series D ledtwitter
Inventiva Pharma $120M equity + €150M debttwitter
Acto celebrates 20 years sponsorless mezzaninetwitter
2025 ESG Report published, sustainability-focusedtwitter
Women In Finance France partnership announcedtwitter
Real Deals Sustainable Investment Awards shortlistedtwitter
PE Magazine Top 3 ranking SMID fundtwitter
6 strategies: Life Sciences, MidCap, Expansion, Acto, Infra, Co-Investwebsite
Spain expansion accelerating via Joaquín Gonzaloexternal
JenaValve FDA approval, first-of-kind deviceexternal
Alveus $160M Series A co-ledexternal
Spiro Medical $67M Series A ledexternal